|
FSTL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08799999962461E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.47029999999438E-05 |
| Normal-vs-Stage2 |
3.630200E-02 |
| Normal-vs-Stage3 |
4.171700E-02 |
| Normal-vs-Stage4 |
9.219200E-01 |
| Stage1-vs-Stage2 |
8.927400E-01 |
| Stage1-vs-Stage3 |
9.279200E-01 |
| Stage1-vs-Stage4 |
9.486400E-02 |
| Stage2-vs-Stage3 |
8.716400E-01 |
| Stage2-vs-Stage4 |
1.380410E-01 |
| Stage3-vs-Stage4 |
8.785700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5059000000317E-06 |
| Normal-vs-AfricanAmerican |
7.970400E-04 |
| Normal-vs-Asian |
5.883800E-01 |
| Caucasian-vs-AfricanAmerican |
8.333000E-01 |
| Caucasian-vs-Asian |
4.678800E-01 |
| AfricanAmerican-vs-Asian |
4.766200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97230000004356E-06 |
| Normal-vs-Female |
2.03789999999593E-05 |
| Male-vs-Female |
2.673000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.442000E-02 |
| Normal-vs-Extreme_Weight |
1.118750E-03 |
| Normal-vs-Obese |
2.627800E-04 |
| Normal-vs-Extreme_Obese |
1.707810E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.460800E-01 |
| Normal_Weight-vs-Obese |
1.132760E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.156000E-01 |
| Extreme_Weight-vs-Obese |
4.215800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.110200E-01 |
| Obese-vs-Extreme_Obese |
8.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.515200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.80350000068242E-08 |
| Normal-vs-Age(61-80Yrs) |
8.815100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.123600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.734400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.551570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.073960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.063600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.882110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.313600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.12829998069708E-09 |
| Normal-VS-Type2 PRCC |
7.422800E-01 |
| Normal-VS-KIRP CIMP |
2.986400E-02 |
| Normal-VS-Unclassified PRCC |
4.964200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.53079771081366E-11 |
| Type1 PRCC-VS-KIRP CIMP |
9.048800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.224000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.239780E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.809300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.015200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.918420E-02 |
| Normal-vs-N1 |
4.366400E-02 |
| Normal-vs-N2 |
1.439810E-01 |
| N0-vs-N1 |
5.350000E-01 |
| N0-vs-N2 |
9.715200E-01 |
| N1-vs-N2 |
8.186600E-01 |
|
|
